200 related articles for article (PubMed ID: 16969268)
1. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS
Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268
[TBL] [Abstract][Full Text] [Related]
2. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
Kim CH; Waldman ID; Blakely RD; Kim KS
Ann N Y Acad Sci; 2008; 1129():256-60. PubMed ID: 18591486
[TBL] [Abstract][Full Text] [Related]
3. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
[TBL] [Abstract][Full Text] [Related]
4. Association of intronic variants of the BTBD9 gene with Tourette syndrome.
Rivière JB; Xiong L; Levchenko A; St-Onge J; Gaspar C; Dion Y; Lespérance P; Tellier G; Richer F; Chouinard S; Rouleau GA;
Arch Neurol; 2009 Oct; 66(10):1267-72. PubMed ID: 19822783
[TBL] [Abstract][Full Text] [Related]
5. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
[TBL] [Abstract][Full Text] [Related]
7. No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD).
Banerjee E; Sinha S; Chatterjee A; Nandagopal K
Neurosci Lett; 2009 May; 454(3):244-8. PubMed ID: 19429092
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups.
Huang SY; Lu RB; Ma KH; Shy MJ; Lin WW
Drug Alcohol Depend; 2008 Jan; 92(1-3):20-6. PubMed ID: 17630229
[TBL] [Abstract][Full Text] [Related]
9. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
[TBL] [Abstract][Full Text] [Related]
10. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
[TBL] [Abstract][Full Text] [Related]
11. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP.
Yang JW; Jang WS; Hong SD; Ji YI; Kim DH; Park J; Kim SW; Joung YS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):243-8. PubMed ID: 17850946
[TBL] [Abstract][Full Text] [Related]
12. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population.
McEvoy B; Hawi Z; Fitzgerald M; Gill M
Am J Med Genet; 2002 Aug; 114(6):665-6. PubMed ID: 12210284
[No Abstract] [Full Text] [Related]
13. Association analysis of serotonin transporter promoter gene polymorphism with ADHD and related symptomatology.
Zhao AL; Su LY; Zhang YH; Tang BS; Luo XR; Huang CX; Su QR
Int J Neurosci; 2005 Aug; 115(8):1183-91. PubMed ID: 16040360
[TBL] [Abstract][Full Text] [Related]
14. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.
Zhao X; Huang Y; Ma H; Jin Q; Wang Y; Zhu G
J Affect Disord; 2013 Aug; 150(1):23-8. PubMed ID: 23648227
[TBL] [Abstract][Full Text] [Related]
15. Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients.
Thompson M; Comings DE; Feder L; George SR; O'Dowd BF
Am J Med Genet; 1998 May; 81(3):241-4. PubMed ID: 9603612
[TBL] [Abstract][Full Text] [Related]
16. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and the biochemical genetics of alcoholism: lessons from studies of attention deficit hyperactivity disorder (ADHD) and Tourette syndrome.
Comings DE
Alcohol Alcohol Suppl; 1993; 2():237-41. PubMed ID: 7748306
[TBL] [Abstract][Full Text] [Related]
18. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.
Kim CH; Hahn MK; Joung Y; Anderson SL; Steele AH; Mazei-Robinson MS; Gizer I; Teicher MH; Cohen BM; Robertson D; Waldman ID; Blakely RD; Kim KS
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19164-9. PubMed ID: 17146058
[TBL] [Abstract][Full Text] [Related]
19. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11.2 a candidate region for Tourette syndrome putative susceptibility genes?
Shelley BP; Robertson MM; Turk J
J Intellect Disabil Res; 2007 Aug; 51(Pt 8):620-4. PubMed ID: 17598875
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
Kereszturi E; Király O; Csapó Z; Tárnok Z; Gádoros J; Sasvári-Székely M; Nemoda Z
Neuropsychopharmacol Hung; 2007 Mar; 9(1):11-8. PubMed ID: 17879560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
